Sponsor Pipeline

Kardigan, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
2
Phase 3
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-05 NCT07210723
A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic…		 Trial sites expanded: 56 -> 78 locations
Active Trials by Phase
Phase 2/3
2
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07001800 Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A… Moderate Aortic Valve Stenosis Recruiting
NCT07210723 A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic… Symptomatic Genetic Dilated Cardiomyopathy Recruiting
Phase 2
NCT07511361 Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization… Hypertension Recruiting
Disease Areas
Hypertension (1)
Get alerts when Kardigan, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free